Effectiveness of anti-tuberculosis chemotherapy in patients with tuberculosis relapse compared with newly diagnosed patients

Вантажиться...
Ескіз

Дата

2020

ORCID

DOI

Науковий ступінь

Рівень дисертації

Шифр та назва спеціальності

Рада захисту

Установа захисту

Науковий керівник

Члени комітету

Видавець

International Journal of Mycobacteriology. – 2019. – Vol. 8, Issue 4 (October-December). – P. 341-346

Анотація

Головна мета статті - вивчити ефективність антитуберкульозної хіміотерапії у пацієнтів з рецидивом туберкульозу легень порівняно з пацієнтами з недавно діагностованим процесом.
Background: To study the effectiveness of antituberculosis chemotherapy in patients with relapse pulmonary tuberculosis (RTB) compared with patients with the newly diagnosed process. Methods: We examined 285 TB patients, including 126 individuals with RTB (Group 1) and 159 patients with newly diagnosed pulmonary tuberculosis (NDPTB) (Group 2). All patients were diagnosed with infiltrative PTB. Effectiveness of the basic course of antimycobacterial treatment was assessed in accordance with the following data: time required for the normalization of clinical manifestations, smear conversion, cavity healing, disappearance of infiltrative and focal changes in the pulmonary tissue, as well as the final clinical effectiveness of therapy. Results: Disappearance of clinical symptoms was statistically significantly faster in Group 2 compared with RTB patients in 2.25 ± 0.11 and 3.40 ± 0.15 months, respectively (P < 0.001). Sputum culture conversion was observed after 6 months of treatment in 138 (86.79%) patients with NDPTB and 89 (72.22%) patients from Group 1 (P = 0.0023). Closure of cavities and disappearance of infiltrative and focal changes in the lungs occurred within 6 months of chemotherapy only in 55 (43.65%) patients with RTB and 93 (58.49%) patients with NDPTB (P = 0.0133). Conclusions: Standard treatment for patients with NDPTB is considered successful in case of faster health improvement and stabilization, less pronounced rates of toxic adverse reactions to antiTB drugs, faster sputum smear and culture conversion and cavity healing, signs of clinical and radiological convalescence, and the reduced number of large residual changes after the treatment compared with RTB.
Главная цель статьи - изучить эффективность антитуберкулезной химиотерапии у пациентов с рецидивом туберкулеза легких по сравнению с пациентами с недавно диагностированным процессом.

Опис

Effectiveness of anti-tuberculosis chemotherapy in patients with tuberculosis relapse compared with newly diagnosed patients / Dmytro Butov, Mykola Gumenuik, Galyna Gumeniuk and oth. // International Journal of Mycobacteriology. – 2019. – Vol. 8, Issue 4 (October-December). – P. 341-346. – DOI: 10.4103/ijmy.ijmy_158_19.
Butov D, Gumenuik M, Gumeniuk G, Tkachenko A, Kikinchuk V, Stepaniuk R, Peshenko A, Butova T. Effectiveness of anti-tuberculosis chemotherapy in patients with tuberculosis relapse compared with newly diagnosed patients. Int J Mycobacteriol 2019;8:341-6
Butov D, Gumenuik M, Gumeniuk G, Tkachenko A, Kikinchuk V, Stepaniuk R, Peshenko A, Butova T. Effectiveness of anti-tuberculosis chemotherapy in patients with tuberculosis relapse compared with newly diagnosed patients. Int J Mycobacteriol [serial online] 2019 [cited 2020 May 20];8:341-6. Available from: http://www.ijmyco.org/text.asp?2019/8/4/341/271478

Ключові слова

publikatsii u zarubizhnomu vydanni, publikatsii u WoS, pulmonary tuberculosis relapse, treatment, tuberculosis, tuberculosis treatment effectiveness, Криміналістика. Criminalistics. Криминалистика, Наукові публікації. Scientific publications. Научные публикации, Медичні науки. Medical sciences. Медицинские науки, туберкульоз, туберкулез, forensic medical examination

Бібліографічний опис